1. Stocks
  2. TG Therapeutics Inc
  3. Swot
swot-logo

TG Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

TG Therapeutics Inc has 21 Strengths, 6 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Week

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Increasing Revenue every Quarter for the past 4 Quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

RSI indicating price weakness

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks